Loxapine
FGA • Last reviewed 2025-09-26
Brands: Loxitane, Adasuve
Sources updated 2025 • 1 references
General Information
Indicated for: Schizophrenia; acute agitation associated with schizophrenia or bipolar I (inhaled). First‑generation antipsychotic (FGA)
Dosage & Administration
Typical dose range: 20–100 mg/day (divided)
Indications (label)
Schizophrenia; acute agitation associated with schizophrenia or bipolar I (inhaled).
View labelExact
Mechanism (brief)
Mid-potency D2 and 5‑HT2A antagonist with H1/M1 blockade.
Metabolism & Half‑life
- Metabolism: CYP1A2, CYP3A4, CYP2D6 to active metabolites.
- Half‑life: ~6–8 h (parent).
Therapeutic Drug Monitoring (TDM)
Recommended: No
References
- Loxapine labelExact (2025)